Industries Market Research Reports

Subscribe to RSS Feed
  1. 27 Dec 2018  |  Global  |  Technology Research

    Microbiome Technologies Fueling Human Health and Wellness

    Emerging Microbiome Platforms Disrupting Pharmaceutical, Food & Beverages and the Consumer Care Industries

    This research service encompasses microbiome technology trends and emerging innovations across: Disease Management This research segment explores the emerging role of microbiome-based therapeutics across a wide range of diseases, especially in the context of gastro-intestinal health, while providing strategic insights across the highly dynamic com...

    $4,950.00
  2. 13 Dec 2018  |  Africa  |  Market Research

    Healthcare Regulatory Environment in Nigeria and Ghana, 2018

    Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement

    The West African region has a handful of emerging economies within Sub-Saharan Africa in terms of overall development and growth. The region currently has a high number of people living in extreme poverty, particularly in Nigeria, as well as a high population density. Furthermore, there has been a growing trend of non-communicable diseases, such as...

    $1,500.00
  3. 12 Dec 2018  |  North America  |  Market Research

    Growth Opportunities in Functional Consumables Aftermarket, Forecast to 2023

    Innovation-as-a-service Business Model will Accelerate Growth in the Molecular Diagnostic Subsegment

    Rapid technological turnaround has become a norm in the life science and in-vitro diagnostic industry. Extrinsic factors such as lack of skilled labor to operate the instrumentation as well as functional factors like demand for very high precision and reproducibility of results are driving this technological evolution. As the instrument efficiency ...

    $4,950.00
  4. 13 Nov 2018  |  Global  |  Technology Research

    Artificial Intelligence Revolutionizing the Pharmaceutical Industry

    Optimal Synergy Between Leading-edge Computational Science and Therapeutics Development

    The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...

    $4,950.00
  5. 12 Nov 2018  |  Asia Pacific  |  Market Research

    Analysis of the Singapore Clinical Laboratories Market, Forecast to 2021

    Laboratory Automation is Driving the Growth of the Clinical Laboratories Market in the Country

    Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...

    $1,500.00
  6. 30 Oct 2018  |  Africa  |  Market Research

    Healthcare Regulatory Environment in Kenya, Tanzania, and Ethiopia, 2018

    Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement

    The East African region boasts of a number of emerging leaders within Sub-Saharan Africa in terms of overall development and growth. On one hand, the region has one of the highest burdens of disease in the world, such as HIV, malaria, and tuberculosis. On the other hand, there has been a growing trend of non-communicable diseases, such as cancers a...

    $1,500.00
  7. 24 Oct 2018  |  North America  |  Market Research

    Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

    A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market

    The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...

    $4,950.00
  8. 22 Oct 2018  |  North America  |  Market Research

    Global Life Sciences Instrumentation and Research Tools Market, Forecast to 2023

    Digitalization and M&As to Transform the Current Competitive Structure of the Industry

    The global life sciences instrumentation and research tools market is currently going through a transformation driven by ongoing market consolidation and technological innovation. Over the past five years, the industry has witnessed more than 50 mergers and acquisitions (M&A), which have resulted in a market consolidation at the top. Most of these ...

    $4,950.00
  9. 05 Oct 2018  |  North America  |  Market Research

    US Point-of-Care Testing Infectious Disease Market, Forecast to 2022

    CLIA Waived Molecular POCT, Coupled with Upcoming Diseases Like Sepsis, Lyme Disease, New Strains of Influenza—H1, H3, and H7, will Drive Growth

    Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...

    $1,500.00
  10. 28 Sep 2018  |  North America  |  Technology Research

    Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments

    A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present

    The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

    $4,950.00